Center For International Blood And Marrow Transplant Research

This study tests a stem cell transplant using donors who are not a perfect match for people with blood cancers like leukemia or lymphoma. The goal is to see if adding certain drugs after the transplant can prevent complications and improve survival. About 300 adults and children …

This study looks at whether using a lower dose of chemotherapy (busulfan) before a stem cell transplant can help babies with severe combined immunodeficiency (SCID) build a strong immune system with fewer side effects. About 56 infants with SCID will receive either a low or moder…

This study tests whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant from a partially matched donor, can reduce serious infections while still preventing graft-versus-host disease (a condition where donor cells attack the patient's body). About 3…

This study looks at whether a sensitive blood test can predict if acute myeloid leukemia (AML) will come back after a stem cell transplant. Researchers will follow 303 adults with AML in remission who are getting a transplant. The goal is to see if this test can help doctors catc…